These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 20581353)

  • 21. Issues in the planning and conduct of randomised trials.
    Bhandari M; Pape HC; Giannoudis PV
    Injury; 2006 Apr; 37(4):349-54. PubMed ID: 16487524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statistical issues in interpreting clinical trials.
    DeMets DL
    J Intern Med; 2004 May; 255(5):529-37. PubMed ID: 15078496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinical significance of new therapies for the management of periodontal disease.
    Van Dyke TE
    J Int Acad Periodontol; 2005 Oct; 7(4 Suppl):191-6. PubMed ID: 16248275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microbiologic surrogate end points in clinical trials of infectious diseases: example of acute otitis media trials.
    Powers JH
    Pharmacotherapy; 2005 Dec; 25(12 Pt 2):109S-123S. PubMed ID: 16305280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical contextualization and the assessment of adverse events in HBOC trials.
    Greenburg AG; Pitman A; Pearce B; Kim HW
    Artif Cells Blood Substit Immobil Biotechnol; 2008; 36(6):477-86. PubMed ID: 19039687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Active-controlled, non-inferiority trials in oncology: arbitrary limits, infeasible sample sizes and uninformative data analysis. is there another way?
    Carroll KJ
    Pharm Stat; 2006; 5(4):283-93. PubMed ID: 17128427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Statistical notes. From superiority to non-inferiority clinical trials: a leap in the dark?].
    Marubini E; Rebora P; Reina G
    Ital Heart J Suppl; 2004 Sep; 5(9):712-9. PubMed ID: 15568609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Conducting a cost-effectiveness trial in oncology: justification and method].
    Lejeune C; Binquet C; Bonnetain F
    Bull Cancer; 2009 May; 96(5):603-7. PubMed ID: 19435689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Designs for efficient clinical trials.
    Simon R
    Oncology (Williston Park); 1989 Jul; 3(7):43-9; discussion 51-3. PubMed ID: 2701811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A primer on the design, conduct, and interpretation of clinical trials.
    Appel LJ
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1360-7. PubMed ID: 17699370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A framework for two-stage adaptive procedures to simultaneously test non-inferiority and superiority.
    Koyama T; Sampson AR; Gleser LJ
    Stat Med; 2005 Aug; 24(16):2439-56. PubMed ID: 15977285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meta-analyses and adaptive group sequential designs in the clinical development process.
    Jennison C; Turnbull BW
    J Biopharm Stat; 2005; 15(4):537-58. PubMed ID: 16022162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statistical considerations for confirmatory clinical trials for similar biotherapeutic products.
    Njue C
    Biologicals; 2011 Sep; 39(5):266-9. PubMed ID: 21807534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A method to enhance determining the clinical relevance of periodontal research data: number needed to treat (NNT).
    Greenstein G; Nunn ME
    J Periodontol; 2004 Apr; 75(4):620-4. PubMed ID: 15152829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statistical analysis of clinical trials.
    Wassertheil-Smoller S; Kim MY
    Semin Nucl Med; 2010 Sep; 40(5):357-63. PubMed ID: 20674595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Equivalence and noninferiority testing in regression models and repeated-measures designs.
    Mascha EJ; Sessler DI
    Anesth Analg; 2011 Mar; 112(3):678-87. PubMed ID: 21304155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design issues in cancer screening trials.
    Moss S
    Stat Methods Med Res; 2010 Oct; 19(5):451-61. PubMed ID: 20442197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biomarkers and surrogates in clinical studies.
    Rigatto C; Barrett BJ
    Methods Mol Biol; 2009; 473():137-54. PubMed ID: 19160736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cautionary tales in the clinical interpretation of trials assessing therapy-induced changes in health status.
    Scott IA
    Int J Clin Pract; 2011 May; 65(5):536-46. PubMed ID: 21489078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adaptive design in clinical research: issues, opportunities, and recommendations.
    Chang M; Chow SC; Pong A
    J Biopharm Stat; 2006 May; 16(3):299-309; discussion 311-2. PubMed ID: 16724486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.